- Home
- RCON vs AWH Comparison
RCON vs AWH Comparison
Compare RCON & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- AWH
- Stock Information
- Founded
- RCON 2007
- AWH 1993
- Country
- RCON China
- AWH United States
- Employees
- RCON N/A
- AWH N/A
- Industry
- RCON Oilfield Services/Equipment
- AWH Medical/Dental Instruments
- Sector
- RCON Energy
- AWH Health Care
- Exchange
- RCON Nasdaq
- AWH Nasdaq
- Market Cap
- RCON 82.6M
- AWH 13.5M
- IPO Year
- RCON 2009
- AWH N/A
- Fundamental
- Price
- RCON $3.40
- AWH $0.85
- Analyst Decision
- RCON
- AWH Buy
- Analyst Count
- RCON 0
- AWH 2
- Target Price
- RCON N/A
- AWH $4.40
- AVG Volume (30 Days)
- RCON 24.8K
- AWH 62.2K
- Earning Date
- RCON 06-28-2024
- AWH 11-11-2024
- Dividend Yield
- RCON N/A
- AWH N/A
- EPS Growth
- RCON N/A
- AWH N/A
- EPS
- RCON N/A
- AWH N/A
- Revenue
- RCON $9,422,141.00
- AWH $8,923,000.00
- Revenue This Year
- RCON N/A
- AWH $15.59
- Revenue Next Year
- RCON $47.32
- AWH $108.47
- P/E Ratio
- RCON N/A
- AWH N/A
- Revenue Growth
- RCON N/A
- AWH N/A
- 52 Week Low
- RCON $1.26
- AWH $0.74
- 52 Week High
- RCON $5.76
- AWH $6.01
- Technical
- Relative Strength Index (RSI)
- RCON 62.22
- AWH 49.98
- Support Level
- RCON $2.79
- AWH $0.76
- Resistance Level
- RCON $3.59
- AWH $0.89
- Average True Range (ATR)
- RCON 0.32
- AWH 0.07
- MACD
- RCON 0.01
- AWH 0.02
- Stochastic Oscillator
- RCON 69.08
- AWH 66.29
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in the sale of oilfield automation products, equipment for oil and gas production and transportation, and engineering services. It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. Majority of the firm's revenue comes from the Automation Product and Software segment.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.